Erchonia has been developing and selling non-invasive 3LT medical equipment since 1996. They have market clearance from FDA for their low-level laser technology products which prompted the FDA to create a new device category called NHN Biostimulation lasers.
Overview
Mentions in press and media 3
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Nov 1, 2021 | FDA Grants 510(k) Market Clearance for Whole Body Postoperative Pain to World Leader in Low Level Laser Technology | As the World Leader in Low Level Laser Technology, we have always believed we need to continue expanding the science of this amazing technology. This latest U.S. FDA 510(k) statement adds to our commitment. MELBOURNE, Fla. (PRWEB) November ... |
| Dec 1, 2020 | Erchonia's Published Peer-Reviewed Results Reveal Promising Treatment for Musculoskeletal Pain | Erchonia FX 635 Laser Erchonia has dedicated the past 25 years to researching solutions for chronic pain. As rewarding as the FDA clearances have been, to now see the data combined into one research article puts into perspective what Erchon... |
Reviews 0
FAQ about Erchonia
When was Erchonia founded?
Erchonia was founded in 1996.
What has the press written about Erchonia?
Parsers VC has collected 3 articles mentioning Erchonia, among them “FDA Grants 510(k) Market Clearance for Whole Body Postoperative Pain to World Leader in Low Level Laser Technology” (Nov 1, 2021) and “Erchonia's Published Peer-Reviewed Results Reveal Promising Treatment for Musculoskeletal Pain” (Dec 1, 2020).
Is Erchonia still active?
Erchonia is probably closed: its latest activity on Parsers VC dates from Feb 22, 2023.